Reference:
Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York, Random House.
Summary:
In “The Truth About the Drug Companies,” Marcia Angell critiques the pharmaceutical industry, highlighting its increasing corruption and the negative impact on clinical research. Drawing from her extensive experience at the New England Journal of Medicine, Angell argues that the commercialisation of drug research began with the Bayh-Dole Act in 1980, allowing universities to patent publicly funded discoveries. As a result, pharmaceutical companies have shifted from genuine innovation to marketing “me-too” drugs, profiting from research largely funded by taxpayers. Angell details how these companies manipulate clinical trial outcomes and maintain cosy relationships with academic institutions, undermining the integrity of medical education. She also reveals the extensive lobbying efforts of the pharmaceutical industry, which has resulted in policies that benefit corporate profits at the expense of public health. Angell calls for systemic changes, such as stricter oversight of clinical research and greater transparency in company finances, to reclaim the integrity of drug development and ensure that health care prioritises patient needs over profits.